Shots:Dr. Harmony gave the details about the positive 12-month findings from the P-IIIb SOLAR trial of the first and only complete long-acting injectable regimen Cabenuva vs. BiktarvyShe also talked about the comparison of the Cabenuva regimen with the other existing & developing products for HIV including the Biktarvy regimenThe interview gives an…
